Company Encyclopedia
View More
name
Euda Health
EUDA.US
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy capsule, stem cell therapy, and CRISPR gene editing treatment services; and supplements. The company also provides property management services. The company is headquartered in Singapore.
379.88 B
EUDA.USMarket value -Rank by Market Cap -/-

Financial Score

11/12/2025 Update
B
Health Care ServicesIndustry
Industry Ranking20/78
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE42.42%A
    • Profit Margin5.17%C
    • Gross Margin27.32%C
  • Growth ScoreA
    • Revenue YoY83.73%A
    • Net Profit YoY101.45%A
    • Total Assets YoY4.66%C
    • Net Assets YoY38.01%A
  • Cash ScoreA
    • Cash Flow Margin1935.07%A
    • OCF YoY83.73%A
  • Operating ScoreA
    • Turnover2.49A
  • Debt ScoreE
    • Gearing Ratio275.57%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    BUZZ-EUDA Health rises after convertible warrant deal

    Shares of Singapore-based healthcare provider EUDA Healthrise 2.4% to $2.90Co says it agreed to sell a $100,000 convertible warrant to investment firm Streeterville CapitalDeal lets Streeterville buy up to 2 mln EUDA shares at $6 each within 90 days, co saysEUDA may require Streeterville to buy 10% of shares if price stays above $7.50 for 5 days, co saysFunds will support expansion in Asia’s non-invasive healthcare market, says EUDA CEO Alfred LimIncluding session’s move, stock down ~34% YTD

    Reuters·
    US
    EUDA
    +5.63%
    Reuters·
    US
    EUDA
    +5.63%

    EUDA Health Holdings Secures Convertible Warrant Agreement

    EUDA Health Holdings announced a securities purchase agreement with an investor for a $100,000 convertible warrant, allowing the purchase of 2,000,000 shares at $6.00 each within 90 days. This may increase share capital and market presence. The latest analyst rating for EUDA stock is a Buy with a $6.00 price target. EUDA operates in the healthcare industry, providing health services and products, and is based in Singapore.

    Tip Ranks·
    US
    EUDA
    +5.63%
    Tip Ranks·
    US
    EUDA
    +5.63%

    EUDA Health Holdings Completes Convertible Note Conversion

    EUDA Health Holdings Limited has completed the conversion of a $162,500 convertible promissory note into 81,250 ordinary shares, finalizing a financial arrangement from August 2025. This move reflects a strategic shift in financial management, enhancing the company's equity base. The decision not to issue further notes under the existing agreement indicates a change in financial strategy. The latest analyst rating for EUDA stock is a Buy with a $6.00 price target. EUDA operates in the healthcare industry, focusing on innovative health solutions.

    Tip Ranks·
    US
    EUDA
    +5.63%
    Tip Ranks·
    US
    EUDA
    +5.63%

    Euda Health Holdings Appoints Huang Bo as Independent Director

    Euda Health Holdings Ltd. has announced the resignation of independent director Wong Kong Yew, effective October 23, 2025. Huang Bo has been appointed as the new independent director, effective October 24, 2025. He will also serve as Chairman of the Compensation Committee and a member of the Audit and Nomination Committees.

    Reuters·
    US
    EUDA
    +5.63%
    Reuters·
    US
    EUDA
    +5.63%

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

    In Tuesday's pre-market session, several health care stocks saw significant movements. Pulmonx (LUNG) gained 19.2% to $1.86, with a market cap of $62 million. Nanobiotix (NBTX) rose 17.04% to $17.65, valued at $727 million. EUDA Health Holdings (EUDA) increased by 12.32% to $2.47, with a market cap of $83 million. Strata Skin Sciences (SSKN) saw an 11.9% rise to $1.88, valued at $9.5 million. Cardio Diagnostics (CDIO) rose 9.97% to $4.3, with a market cap of $6.8 million, while Nutriband (NTRB) increased by 9.81% to $7.72, valued at $84.4 million.

    Benzinga·
    US
    LUNG
    -0.61%
    US
    SSKN
    +4.14%
    US
    EUDA
    +5.63%
    Benzinga·
    US
    LUNG
    -0.61%
    US
    SSKN
    +4.14%
    US
    EUDA
    +5.63%
    © 2025 Longbridge｜Disclaimer